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To date (end 1987) we have provided a continuous epidural for over 31,500 labouring mothers. Approximately 126,000 top-ups will have been given by our midwives during the course of these procedures. Throughout this period we have encountered three occasions on which bupivacaine was, subsequent to the first formal dose (always given by the anaesthetist), directly injected into the blood stream (twice) or the CSF (once): incidences respectively of 1:63,000 and 1:126,000 maintenance top-ups.
The main concern displayed by Dain et al. appears to be with the danger of an inadvertent intrathecal injection, hence their tentative support of the advocacy that 1.5 per cent lidocaine in 7.5 per cent dextrose might be the ideal solution, although currently they consider 30-50 mg in a one to two per cent solution is the test dose of choice. Contrary to the opinions expressed by Dain et al. and by Biehl, I do not believe that the test doses they describe will inevitably afford evidence of an inadvertent intravascular injection. We have encountered cases of peri-oral tingling and other signs which have led us to re-insert the epidural catheter, but our one case of massive intravascular injection of bupivacaine given on the initial injection occurred despite the fact that a test dose of 2 ml, 1.0 per cent lidocaine five minutes previously had evoked no response. 3 Incidentally, I whole-heartedly support those who decline to include epinephrine in the test dose, for reasons well presented by Dain et al.
If, then, hyperbaric lidocaine is to be used to define an inadvertent intrathecal injection, for obvious reasons the mother must be sitting upright during the injection and for several minutes after. Additional to the fuss involved in the inspection, identification (by a witness) and injection of two different solutions, such a procedure will inevitably make considerable extra demands upon midwifery time, as well as causing the mother some stress (she might well have to be helped from, and then back to, a lateral horizontal position). All to avoid a complication with an incidence of one in an eighth of a million.
Again, such a procedure is itself not free from potential hazard. We have administered approximately 1500 spinal anaesthetics in this hospital -admittedly a much smaller CANAD1AN JOURNAL OF ANAESTHESIA experience than that of the majority of North American Obstetric Units. We invariably use five per cent lidocaine in six per cent dextrose 1.2-1.5 ml, injected whilst the mother sits upright. On two occasions the block has extended so far cephalad that tracheal intubation and assisted ventilation has been required. Why invite such a complication?
I agree that it is advisable to attempt to aspirate before injecting through the cannula (we never administer single shot epidurals via a needle), but, of greater importance, 1 emphatically support the advocacy of your contributors that top-ups must be given in increments. Our maximum volume of bupivacaine injected at any one time has, for several years, been 5 ml. It is somewhat anomalous that we impose that maximum irrespective of whether the solution is 0.25 pet cent or 0.5 per cent, hut that is another matter for debate. 1 believe that to be the most important safety measure in our practice -a limitation of potential hazard rather than an avoidance. We do still employ a test dose (2 ml, 1.0 per cent ]idocaine plain) before giving the first formal dose of bupivacaine, but 1 doubt that it has much value, other than ensuring that the cannula is patent, and does not become clogged up with protein before alI is ready to continue with the procedure. 
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